Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Cited by (1,005)

Items 501–600 of 1,005

1. Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
   Gregory Y.H. Lip, Amitava Banerjee, I. Lagrenade, Deirdre A. Lane, Sophie Taillandier, Laurent Fauchier · 2012 · Circulation Arrhythmia and Electrophysiology
2. Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
   Frank L.J. Visseren, François Mach, Yvo Michiel Smulders, David Carballo, Konstantinos C. Koskinas, Maria Bäck, Athanase Bénétos, Alessandro Biffi, José Manuel Boavida, Davide Capodanno et al. · 2022 · Revista Española de Cardiología
3. New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry
   Anna Rosenblatt, Colby R. Ayers, Anjali Rao, Stacey J. Howell, NICHOLAS S. HENDREN, Ronit H. Zadikany, Joseph E. Ebinger, James D. Daniels, Mark S. Link, James A. de Lemos et al. · 2022 · Circulation Arrhythmia and Electrophysiology
4. Postoperative atrial fibrillation (POAF) after cardiac surgery: clinical practice review
   Orlando R. Suero, Ahmed K. Ali, Lauren M. Barron, Matthew W. Segar, Marc Richard Moon, Subhasis Chatterjee · 2024 · Journal of Thoracic Disease
5. Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study
   Shadi R. Yaghi, Amelia K. Boehme, Rebecca Hazan, Eldad A. Hod, Alberto Canaan, Howard Andrews, Hooman Kamel, Randolph S. Marshall, Mitchell S.V. Elkind · 2015 · Journal of Stroke and Cerebrovascular Diseases
6. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients
   Gregory Y.H. Lip, Deirdre A. Lane · 2009 · Thrombosis and Haemostasis
7. Ischemic Stroke and Secondary Prevention in Clinical Practice
   Signild Åsberg, Karin Maria Henriksson, Bahman Y. Farahmand, Kjell Asplund, Bo G Norrving, Peter Appelros, Birgitta Stegmayr, Kerstin Hulter Åsberg, Andreas Terént · 2010 · Stroke
8. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial
   Berend Daan Westenbrink, Marco Alings, Stuart J. Connolly, John W. Eikelboom, M. D. Ezekowitz, Jonas Oldgren, Sean Yang, J. Pongue, Salim Yusuf, Lars C. Wallentin et al. · 2015 · Journal of Thrombosis and Haemostasis
9. ‘Real-world’ management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme–Atrial Fibrillation (EORP-AF) General Pilot Registry
   Giuseppe Boriani, Cécile Laroche, Igor Diemberger, Elisa Fantecchi, Mircea Ioachim Popescu, Lars Hvilsted Rasmussen, Gheorghe‐Andrei Dan, Zbigniew F. Kalarus, Luigi Tavazzi, Aldo Pietro Maggioni et al. · 2016 · EP Europace
10. Cerebrovascular disease
    Marileen L.P. Portegies, Peter J. Koudstaal, M. Arfan Ikram · 2016 · Handbook of clinical neurology
11. Oclusão do apêndice atrial esquerdo com o Amplatzer Cardiac Plug em pacientes com fibrilação atrial
    Ênio Eduardo Guérios, Michael Schmid, Steffen Gloekler, Ahmed Aziz Khattab, Peter Wenaweser, Stephan Windecker, Bernhard Meier · 2012 · Arquivos Brasileiros de Cardiologia
12. Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences
    Jeff R. Schein, Charles Michael White, Winnie W. Nelson, Jeffrey Kluger, Elizabeth S. Mearns, Craig Ian Coleman · 2016 · Thrombosis Journal
13. Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
    Min‐Seok Kim, Ju‐Hee Lee, Eung Ju Kim, Dae-Gyun Park, Sung‐Ji Park, Jin Joo Park, Mi‐Seung Shin, Byung‐Su Yoo, Jong‐Chan Youn, Sang Eun Lee et al. · 2017 · Korean Circulation Journal
14. Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants
    Tomas Forslund, Joris J. Komen, Morten Tolstrup Andersen, Björn Wettermark, Mia von Euler, Aukje Kaija Mantel-Teeuwisse, Frieder Braunschweig, Paul Hjemdahl · 2018 · Stroke
15. Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation
    Renato D. Lópes, Christopher Bull Granger, DANIEL M. WOJDYLA, William F. McIntyre, Marco Alings, Thenmozhi Mani, Chinthanie F. Ramasundarahettige, Léna Rivard, Dan Atar, David H. Birnie et al. · 2024 · Journal of the American College of Cardiology
16. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation
    Carlos A Salazar, Daniel del Aguila, Erika G. Cordova-Ramos · 2014 · Cochrane Database of Systematic Reviews
17. Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
    Zachary A. Stacy, William B. Call, Aaron P. Hartmann, Golden L. Peters, Sara K. Richter · 2016 · Cardiology and Therapy
18. Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin
    Yi‐Hsin Chan, Yung‐Hsin Yeh, Lai‐Chu See, Chunli Wang, Shang‐Hung Chang, Hsin‐Fu Lee, Lung‐Sheng Wu, Hui‐Tzu Tu, Chi-Tai Kuo · 2016 · Journal of the American College of Cardiology
19. Prognosis and Guideline-Adherent Antithrombotic Treatment in Patients With Atrial Fibrillation and Atrial Flutter
    Laurent Gorin, Laurent Fauchier, Emilie Nonin, B Charbonnier, Dominique Babuty, Gregory Y.H. Lip · 2011 · CHEST Journal
20. Atrial Fibrillation, Stroke, and Anticoagulation in Medicare Beneficiaries: Trends by Age, Sex, and Race, 1992–2010
    Gautam R. Shroff, Craig A. Solid, Charles A. Herzog · 2014 · Journal of the American Heart Association
21. Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
    Johan Lyth, Emma Svennberg, Lars Bernfort, Mattias Aronsson, Viveka Frykman, Faris Al‐Khalili, Leif Friberg, Mårten Rosenqvist, Johan Engdahl, Lars‐Åke Levin · 2022 · European Heart Journal
22. Aspirin: Pharmacology and Clinical Applications
    Enma Verónica Paez Espinosa, John Paul Murad, Fadi T. Khasawneh · 2011 · Thrombosis
23. Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis
    Mark Findlay, Peter C. Thomson, Rachael L. Fulton, Marit Dahl Solbu, Alan G. Jardine, Rajan Kantilal Patel, Kathryn K. Stevens, Colin Geddes, Jesse Dawson, Patrick Barry Mark · 2015 · Stroke
24. Associations between Cardioembolic Stroke and Obstructive Sleep Apnea
    Melissa C. Lipford, Kelly D. Flemming, Andrew D. Calvin, Jay N. Mandrekar, Robert D. Brown, Virend Kristen Somers, Sean M. Caples · 2015 · SLEEP
25. Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
    Robert Patrick Giugliano, Christian Thomas Ruff, Stephen D. Wiviott, Francesco Nordio, Sabina A. Murphy, Johannes A.N. Kappelhof, Minggao Shi, Michele F. Mercuri, Elliott Marshall Antman, Eugene Braunwald M. D · 2016 · The American Journal of Medicine
26. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study‐level meta‐analysis of phase III randomized trials
    Giuseppe Patti, Giuseppe Di Gioia, Ilaria Cavallari, Antonio Nenna · 2016 · Diabetes/Metabolism Research and Reviews
27. Development and validation of a score to detect paroxysmal atrial fibrillation after stroke
    Timo Uphaus, Mark Weber-Krüger, Martin Grond, Gerrit Toenges, Antje Jahn‐Eimermacher, Marek Jauss, Paulus F. Kirchhof, Rolf Wachter, Klaus Gröschel · 2018 · Neurology
28. Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people
    Olivier Hanon, Patrick Assayag, Joël Belmin, Jean‐Philippe Collet, J.P. Émeriau, Laurent Fauchier, Françoise Forette, Patrick Friocourt, Armelle Gentric, Christophe Leclercq et al. · 2013 · Archives of cardiovascular diseases
29. Epidemiology, organization, diagnosis and treatment of acute ischemic stroke
    Carolina Capirossi, Antonio Laiso, Leonardo Renieri, Francesco Capasso, Nicola Limbucci · 2023 · European Journal of Radiology Open
30. Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation
    Ben Freedman, Carlos Martínez, Anja Katholing, Stephan Rietbrock · 2016 · JAMA Cardiology
31. Can We Rely on RE-LY?
    Brian F. Gage · 2009 · New England Journal of Medicine
32. Relation of Effective Anticoagulation in Patients With Atrial Fibrillation to Stroke Severity and Survival (from the National Acute Stroke Israeli Survey [NASIS])
    Yvonne Schwammenthal, Natan M. Bornstein, Ehud Schwammenthal, Roseline Schwartz, Uri Goldbourt, Rakefet Tsabari, Silvia Koton, Ehud Grossman, David Tanné · 2009 · The American Journal of Cardiology
33. Características de los pacientes y abordaje terapéutico de la fibrilación auricular en atención primaria en España: Estudio FIATE
    José María Lobos-Bejarano, José Carlos del Castillo Rodríguez, Amparo Mena González, José Juan Alemán-Sánchez, Antonio Cabrera de León, Gonzalo Barón‐Esquivias, Agustín Pastor Fuentes · 2013 · Medicina Clínica
34. Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism
    Jan Steffel, Eugene Braunwald · 2011 · European Heart Journal
35. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection
    Jonathan Paul Piccini, Horst Sievert, Manesh R. Patel · 2016 · European Heart Journal
36. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation—Rationale and design of the ENVISAGE-TAVI AF trial
    Nicolas M. Van Mieghem, Martin Unverdorben, Marco Valgimigli, Roxana Mehran, Eric H. Boersma, Usman Baber, Christian Hengstenberg, Minggao Shi, Cathy Yi-Hsuan Chen, Shigeru Saito et al. · 2018 · American Heart Journal
37. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
    Rustam Al‐Shahi Salman, Jacqueline Stephen, Jayne F. Tierney, Steff C. Lewis, David Ernest Newby, Adrian Parry‐Jones, Phil White, Stuart J. Connolly, Oscar Benavente, Dar D Dowlatshahi et al. · 2023 · The Lancet Neurology
38. Prediction of incident atrial fibrillation using deep learning, clinical models, and polygenic scores
    Gilbert Jabbour, Alexis Nolin-Lapalme, Olivier Tastet, Denis Corbin, Paloma Jordà, Achille Sowa, Jacques Delfrate, David Busseuil, Julie Hussin, Marie‐Pierre Dubé et al. · 2024 · European Heart Journal
39. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006
    Yannick Béjot, D. Ben Salem, Guy‐Victor Osseby, Grégory Couvreur, Jérôme Durier, Christine Marie, Yves Cottin, Thibault Moreau, Maurice Giroud · 2009 · Neurology
40. Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations
    Jeff S. Healey, Ratika Parkash, Tim Pollak, Teresa S.M. Tsang, Paul Dorian · 2011 · Canadian Journal of Cardiology
41. Clinical evaluation of laboratory methods to monitor apixaban treatment in patients with atrial fibrillation
    Mika Skeppholm, Fadiea Al-Aieshy, Maria Berndtsson, Faris Al‐Khalili, Yuko Rönquist-Nii, Lisbeth Söderblom, A. Östlund, Anton Pohanka, Jovan P. Antović, Rickard E. Malmström · 2015 · Thrombosis Research
42. Stroke Risk and Antithrombotic Strategies in Atrial Fibrillation
    CAROLINE MEDI, Graeme J. Hankey, Saul B. Freedman · 2010 · Stroke
43. Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation
    Adrian Matthew Shields, Gregory Y.H. Lip · 2015 · Journal of Internal Medicine
44. Misperceptions of aspirin efficacy and safety may perpetuate anticoagulant underutilization in atrial fibrillation
    Ben Freedman, Bernard J. Gersh, Gregory Y.H. Lip · 2014 · European Heart Journal
45. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016
    Matthew James Alcusky, David D. McManus, Anne Lamont Hume, Marc Fisher, Jennifer Tjia, Kate L. Lapane · 2019 · Journal of the American Heart Association
46. All-Cause and Bleeding-Related Health Care Costs in Warfarin-Treated Patients with Atrial Fibrillation
    Sameer R. Ghate, JOSEPH E. BISKUPIAK, Xiangyang Ye, Winghan Jacqueline Kwong, Diana I Brixner · 2011 · Journal of Managed Care Pharmacy
47. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents
    Tomoaki Matsumura, Makoto Arai, Daisuke Maruoka, Kenichiro Okimoto, Shoko Minemura, Hideaki Ishigami, Keiko Saito, Tomoo Nakagawa, Tatsuro Katsuno, Osamu Yokosuka · 2014 · BMC Gastroenterology
48. Management of Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation in the Setting of Acute Coronary Syndromes or Percutaneous Coronary Interventions
    Davide Capodanno, Dominick Joseph Angiolillo · 2014 · Circulation Cardiovascular Interventions
49. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey
    Tim Holt, Tina D. Hunter, Candace Gunnarsson, Nada Khan, Paul Cload, Gregory Y.H. Lip · 2012 · British Journal of General Practice
50. Left atrial size and risk of stroke in patients in sinus rhythm
    Thure Filskov Overvad, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Peter Søgaard · 2016 · Thrombosis and Haemostasis
51. Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
    Yukihiro Koretsune, Takeshi Yamashita, Tetsuya Kimura, Masayuki Fukuzawa, Kenji Abe, Masahiro Yasaka · 2015 · Circulation Journal
52. New Oral Anticoagulants Should Not Be Used as First-Line Agents to Prevent Thromboembolism in Patients With Atrial Fibrillation
    Jack Ansell · 2012 · Circulation
53. Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants
    Emmanuel Touzé, Yves Gruel, Isabelle Gouin‐Thibault, Emmanuel de Maistre, Sophie Susen, Piérre Siè, Laurent Derex · 2018 · European Journal of Neurology
54. Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal
    Nicole Lowres, Katrina Giskes, Charlotte Mary Hespe, Ben Freedman · 2019 · Korean Circulation Journal
55. Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
    Bruce Sheldon Stambler, Leonard Mzee Ngunga · 2015 · International Journal of General Medicine
56. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study
    Ying Xian, Jingjing Wu, Emily Claire O'Brien, Gregg C. Fonarow, DaiWai M. Olson, Lee H. Schwamm, Deepak L. Bhatt, Eric Edward Smith, Robert E. Suter, Deidre Hannah et al. · 2015 · BMJ
57. Detection of Paroxysmal Atrial Fibrillation in Acute Stroke Patients
    Timolaos Rizos, C. Rasch, Ekkehart Jenetzky, Christian Hametner, S. Kathoefer, Roland Reinhardt, Thomas Hepp, Werner Hacke, Roland C. Veltkamp · 2010 · Cerebrovascular Diseases
58. Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
    Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi, Shin‐ichi Momomura, Shinichiro Uchiyama, Shinya Goto, Tohru Izumi, Yukihiro Koretsune, Mariko Kajikawa, Masaharu C. Kato et al. · 2013 · Circulation Journal
59. Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke
    Kanjana S. Perera, Thomas Vanassche, Jackie Bosch, Balakumar Swaminathan, Hardi Mundl, Mohana Giruparajah, Miguel Angel Barboza, Martin James O'Donnell, Maia Gómez Schneider, Graeme J. Hankey et al. · 2016 · Stroke
60. Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
    Inmaculada Hernandez, Meiqi He, Nemin Chen, Maria M. Brooks, Samir Saba, Walid F. Gellad · 2019 · Journal of the American Heart Association
61. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation
    Michaël Benzimra, Béatrix Bonnamour, Martin Duracinský, Christophe Lalanne, Jean-Pierre Aubert, Olivier Chassany, Isabelle Aubin-Auger, Isabelle Mahé · 2018 · Patient Preference and Adherence
62. The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey
    Mauro Molteni, Hernan Polo Friz, Laura PRIMITZ, Giuseppe Marano, Patrizia Boracchi, Claudio Cimminiello · 2014 · EP Europace
63. Temporal Trends in the Incidence, Prevalence, and Survival of Patients With Atrial Fibrillation From 2004 to 2016
    Brent A. Williams, Ashley M. Honushefsky, Peter B. Berger · 2017 · The American Journal of Cardiology
64. Stratifying Stroke Risk in Atrial Fibrillation
    Shadi R. Yaghi, Hooman Kamel · 2017 · Stroke
65. Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
    Jean‐Pierre Bassand, Saverio Virdone, Marc Badoz, Freek W.A. Verheugt, A. John Camm, Frank J.S. Cools, Keith A.A. Fox, Samuel Zachary Goldhaber, Shinya Goto, Sylvia K. Haas et al. · 2021 · Blood Advances
66. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation
    Utibe R. Essien, Karen Chiswell, Lisa A. Kaltenbach, Tracy Y Wang, Gregg C. Fonarow, Kevin L. Thomas, Mintu P. Turakhia, Emelia J. Benjamin, Fátima Rodríguez, Margaret C. Fang et al. · 2022 · JAMA Cardiology
67. Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives
    Jules Mesnier, Pedro Luis Cepas Guillén, Xavier Freixa, Eduardo Flores‐Umanzor, Kim Hoang Trinh, Gilles E O’Hara, Josep Rodés‐Cabau · 2023 · Circulation Cardiovascular Interventions
68. Paroxysmal Atrial Fibrillation Is More Prevalent than Persistent Atrial Fibrillation in Acute Stroke and Transient Ischemic Attack Patients
    Timolaos Rizos, A. Wagner, Ekkehart Jenetzky, Peter Arthur Ringleb, R Becker, Werner Hacke, Roland C. Veltkamp · 2011 · Cerebrovascular Diseases
69. Management of Atrial Fibrillation in Critically Ill Patients
    Mattia Arrigo, Dominique Béttex, Alain Rudiger · 2014 · Critical Care Research and Practice
70. New oral anticoagulants in elderly patients
    Stefano Barco, Y. Whitney Cheung, John W. Eikelboom, Michiel Coppens · 2013 · Best Practice & Research Clinical Haematology
71. The Impact of Smoking on Thromboembolism and Mortality in Patients With Incident Atrial Fibrillation
    Ida Ehlers Albertsen, Lars Hvilsted Rasmussen, Deirdre A. Lane, Thure Filskov Overvad, Flemming Skjøth, Kim Overvad, Gregory Y.H. Lip, Torben Bjerregaard Larsen · 2013 · CHEST Journal
72. Outcomes registry for better informed treatment of atrial fibrillation II: Rationale and design of the ORBIT-AF II registry
    Benjamin Adam Steinberg, Rosalia G Blanco, Donna M Ollis, Sunghee Kim, DaJuanicia N. Holmes, Peter Russell Kowey, Gregg C. Fonarow, Jack Ansell, Bernard John Gersh, Alan S. Go et al. · 2014 · American Heart Journal
73. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population
    Alpesh Amin, Allison V. Keshishian, Jeffrey N. Trocio, Oluwaseyi Dina, Hannah Le, Lisa C. Rosenblatt, Xianchen Liu, Jack Mardekian, Qisu Zhang, Onur Başer et al. · 2017 · Current Medical Research and Opinion
74. MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation
    Ana B. Arroyo, Ascensión M. de los Reyes‐García, José Miguel Rivera‐Caravaca, Patricia Valledor, Nuria García‐Barberá, Vanessa Roldán, Vicente Vicente, Constantino Martı́nez, Rocío Gónzález‐Conejero · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
75. Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis
    Lorin Froehlich, Pascal B. Meyre, Stefanie Aeschbacher, Steffen Blum, Daniela Djokic, M Kuehne, Stefan Osswald, Beat A. Kaufmann, David Conen · 2019 · Heart
76. Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Stephan Henrik Schirmer, Magnus Baumhäkel, Hans‐Ruprecht Neuberger, Stefan Hans Hohnloser, Isabelle C. Van Gelder, Gregory Y.H. Lip, Michael Böhm · 2010 · Journal of the American College of Cardiology
77. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention
    Erasmia Broussalis, Monika Killer‐Oberpfalzer, Mark R. McCoy, Andrea Harrer, Eugen Trinka, Jörg Kraus · 2011 · Drug Discovery Today
78. Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
    Roger E. G. Schutgens, Víctor Jiménez‐Yuste, Miguel Antonio Escobar, Anna Falanga, Bruna Gigante, Robert Klamroth, Riitta Lassila, Frank W.G. Leebeek, Michael Makris, Tarek M. Owaidah et al. · 2023 · HemaSphere
79. Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink
    Ana Filipa Macedo, James Bell, C. McCarron, Rachel Conroy, James Richardson, Anna Scowcroft, Tom Sunderland, Naj Rotheram · 2015 · Thrombosis Research
80. Effect of Genetic Variants, Especially CYP2C9 and VKORC1, on the Pharmacology of Warfarin
    Nikolaos A. Patsopoulos, Steven M. Belknap, Daniel J. O’Rourke, John F. Robb, Jeffrey L. Anderson, Nicholas W. Shworak, Jason H. Moore, Erik Fung · 2012 · Seminars in Thrombosis and Hemostasis
81. Factors that influence awareness and treatment of atrial fibrillation in older adults
    John Frewen, C. Finucane, Hilary Cronin, C. Rice, Patricia M. Kearney, Joseph A. Harbison, Rose Anne Kenny · 2013 · QJM
82. Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation
    Lien Desteghe, Johan M. Vijgen, Pieter Koopman, Dagmara M. Dilling-Boer, Joris Schurmans, Paul Dendale, Hein Heidbüchel · 2017 · European Heart Journal
83. Stroke Prevention in Nonvalvular Atrial Fibrillation
    Mohamad Adnan Alkhouli, Peter A. Noseworthy, Charanjit S. Rihal, David R. Holmes · 2018 · Journal of the American College of Cardiology
84. Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta‐Analysis
    Larisa G. Tereshchenko, Charles A. Henrikson, Joaquin E. Cigarroa, Jonathan S. Steinberg · 2016 · Journal of the American Heart Association
85. Prevalence and Characteristics of Subclinical Atrial Fibrillation in a Community-Dwelling Elderly Population
    Mary R. Rooney, Elsayed Z. Soliman, Pamela L. Lutsey, Faye L. Norby, Laura R. Loehr, Thomas H. Mosley, Michael J. Zhang, Rebecca F. Gottesman, Josef Coresh, Aaron R. Folsom et al. · 2019 · Circulation Arrhythmia and Electrophysiology
86. Mortality in atrial fibrillation. Is it changing?
    Álvaro Alonso, Zakaria Almuwaqqat, Alanna M. Chamberlain · 2020 · Trends in Cardiovascular Medicine
87. Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: A nationwide population-based cohort study
    Hyo‐Jeong Ahn, So‐Ryoung Lee, Eue‐Keun Choi, Kyungdo Han, Jin‐Hyung Jung, Jaehyun Lim, Jun Pil Yun, Soonil Kwon, Seil Oh, Gregory Y.H. Lip · 2021 · PLoS Medicine
88. Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial Fibrillation
    Neal Yuan, Grant Duffy, Sanket Shishir Dhruva, Adam Oesterle, Cara N. Pellegrini, John Theurer, Marzieh Vali, Paul A. Heidenreich, Salomeh Keyhani, David Ouyang · 2023 · JAMA Cardiology
89. Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper
    Tatjana Potpara, Marek Grygier, Karl Georg Hæusler, Jens Erik Nielsen‐Kudsk, Sérgio Luis Berti, Simonetta Genovesi, Éloi Marijon, Serge Bovéda, Apostolos Tzikas, Giuseppe Boriani et al. · 2024 · EP Europace
90. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans
    Elizabeth Ellen Roughead, John D. Barratt, Emmae N. Ramsay, Nicole L. Pratt, Philip Ryan, R. Peck, Graeme T Killer, Andrew L. Gilbert · 2010 · Journal of Clinical Pharmacy and Therapeutics
91. Should We Recommend Oral Anticoagulation Therapy in Patients With Atrial Fibrillation Undergoing Coronary Artery Stenting With a High HAS-BLED Bleeding Risk Score?
    Juan M. Ruiz-Nodar, Francisco R. Marín, Vanessa Roldán, José Valencia, Sergio Manzano‐Fernández, Luis Caballero, José Antonio Hurtado, Francisco Sogorb, Mariano Valdés, Gregory Y.H. Lip · 2012 · Circulation Cardiovascular Interventions
92. Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials
    Thomas Vanassche, Jack Hirsh, Jeffrey S. Ginsberg, John W. Eikelboom · 2014 · Thrombosis and Haemostasis
93. Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications
    Claire E. Raphael, Paul Friedman, Jacqueline Saw, Sorin V. Pislaru, Thomas M. Munger, David R. Holmes · 2017 · EuroIntervention
94. Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study
    Chris Wilkinson, Andrew Paul Clegg, Oliver M. Todd, Kenneth J. Rockwood, Mohammad Esmaeil Yadegarfar, Chris P Gale, Marlous Hall · 2020 · Age and Ageing
95. Treatment of Atrial Fibrillation in Patients with Dementia: A Cohort Study from the Swedish Dementia Registry
    Ana Šubic, Pavla Čermáková, Dorota Religa, Shuang Han, Mia von Euler, Ingemar Kåreholt, Kristina Johnell, Johan Fastbom, Liselia Bognandi, Bengt G. Winblad et al. · 2017 · Journal of Alzheimer s Disease
96. Atrial fibrillation: prevalence in a large database of primary care patients in Brazil
    Milena Soriano Marcolino, Daniel Moore-Palhares, Emelia J. Benjamin, Antônio Luiz Pinho Ribeiro · 2015 · EP Europace
97. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study
    Minako Wakasugi, Junichiro James Kazama, Akihide Tokumoto, Kensuke Suzuki, Shinji Kageyama, Kaoru Ohya, Yoshiaki Miura, Mamoru Kawachi, Takuma Takata, Masaaki Nagai et al. · 2013 · Clinical and Experimental Nephrology
98. Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives
    Pablo Alonso‐Coello, Víctor M. Montori, M. Gloria Díaz, Philip James Devereaux, Gemma Mas Dalmau, A.I. Fernández Díez, Iván Solà, Mercè Roura, Juan Carlos Souto, Sven Oliver et al. · 2014 · Health Expectations
99. Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
    Karsten Bruins Slot, Eivind Berge · 2013 · Stroke
100. Alcohol intake and prognosis of atrial fibrillation
     Thure Filskov Overvad, Lars Hvilsted Rasmussen, Flemming Skjøth, Kim Overvad, Ida Ehlers Albertsen, Deirdre A. Lane, Gregory Y.H. Lip, Torben Bjerregaard Larsen · 2013 · Heart